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Background. Alterations in expression of hepatic genes that could contribute to resistance to dietary cholesterol were investigated
in Sprague-Dawley rats, which are known to be resistant to the serum cholesterol raising action of dietary cholesterol. Methods.
Microarray analysis was used to provide a comprehensive analysis of changes in hepatic gene expression in rats in response to
dietary cholesterol. Changes were conﬁrmed by RT-PCR analysis. Western blotting was employed to measure changes in hepatic
cholesterol 7α hydroxylase protein. Results. Of the 28,000 genes examined using the Aﬀymetrix rat microarray, relatively few were
signiﬁcantly altered. As expected, decreases were observed for several genes that encode enzymes of the cholesterol biosynthetic
pathway. The largest decreases were seen for squalene epoxidase and lanosterol 14α demethylase (CYP 51A1). These changes were
conﬁrmed by quantitative RT-PCR. LDL receptor expression was not altered by dietary cholesterol. Critically, the expression of
cholesterol7αhydroxylase,whichcatalyzestherate-limitingstepinbileacidsynthesis,wasincreasedover4-foldinliversofratsfed
dietscontaining1%cholesterol.Incontrast,mice,whicharenotresistanttodietarycholesterol,exhibitedlowerhepaticcholesterol
7α hydroxylase (CYP7A1) protein levels, which were not increased in response to diets containing 2% cholesterol.
1.Introduction
There is considerable variation among animals and humans
in terms of their responses to consumption of excess dietary
cholesterol. Consumption of a high-cholesterol diet does not
automatically result in elevated serum cholesterol levels due
to the operation of adaptive responses. Rabbits, hamsters,
and C57BL/6 mice are not resistant to dietary cholesterol
and exhibit marked elevations in serum cholesterol levels
when given diets supplemented with cholesterol [1–3]. On
the other hand, rats such as Sprague-Dawley, Wistar-Furth,
Spontaneously Hypertensive or Fischer 344 show very little if
any increase in serum cholesterol levels when given a similar
cholesterol challenge [2]. For most humans, consumption of
increasedamountsofdietarycholesterolproducesonlysmall
increases in both LDL and HDL cholesterol with little eﬀect
on the ratio of LDL to HDL [4, 5]. In a 14-year study of
over80,000femalenurses,eggconsumptionwasunrelatedto
the risk of coronary heart disease [4]. On balance, extensive
epidemiologic studies show that dietary cholesterol is not
a contributor to increased heart disease risk in humans
[6]. Clearly, in many rat strains and most people, adaptive
responses are operating that keep serum cholesterol levels
within the normal range.
Multiple possible mechanisms may be operating to pro-
vide a person or animal with resistance to the serum cho-
lesterol-raising action of dietary cholesterol. These include
decreasing the rateof cholesterolbiosynthesis, decreasing the
rate of cholesterol absorption, increasing the rate of choles-
terol excretion, increasing the conversion of cholesterol to
bile acids, and increasing the rate of removal of serum cho-
lesterol via liver lipoprotein receptors [7, 8].
Inordertoobtainacomprehensiveandunbiasedanalysis
of adaptive responses in hepatic gene expression to dietary
cholesterol, we carried out microarray analysis of changes in
Sprague-Dawley rat liver gene expression elicited by a 1%
cholesterol diet. These animals are known to have adaptive
responsesthatrenderthemresistanttodietarycholesterol.In
order to induce atherosclerotic plaques in these animals, the
rats must be rendered hypothyroid [9]. Thus, this animal is a
reasonablemodelforhumanresponsestodietarycholesterol.
In a previous microarray study, C57BL/6 mice were used2 Journal of Lipids
[10] .T h e s em i c eb e c o m eh y p e r c h o l e s t e r o l e m i ca n dd e v e l o p
fatty lesions in their ascending aortas when given diets
supplemented with cholesterol [11, 12].
Liver was selected for extensive study, because this tissue
not only synthesizes cholesterol but also is also responsible
for bile acid production and excretion of cholesterol and
expresses the majority of the body’s LDL receptors [13].
2. Methods
2.1. Animals. Male Sprague-Dawley rats, 150–200g (Harlan,
Madison, Wis, USA), were fed Harlan Teklad 22/5 rodent
chow with or without 1% cholesterol for ﬁve days. The
animals were kept in a reversed lighting cycle room (12
dark/12hrs light) and sacriﬁced at 0900–1000hrs, corre-
sponding to the third to fourth hour of the dark period
when cholesterol biosynthesis is maximal. Twelve-week old
C57BL/6Jmicewerefedchowwithorwithout2%cholesterol
for 5 days. Liver samples were obtained, and microsomes
were prepared from both rats and mice [14]. All procedures
were carried out according to the regulations and oversight
of the University of South Florida Institutional Animal Care
and Use Committee (IACUC), protocol 2953.
2.2. Cholesterol Analysis. Trunk blood was collected and al-
lowed to clot. The samples were centrifuged at 5,000xg for
5min. The serum was removed with a Pasteur pipette. Total
serum cholesterol levels were determined by a cholesterol
oxidase method using Inﬁnity Cholesterol Reagent (Sigma)
[15]. Values are expressed as mg/dL of serum. Liver choles-
t e r o ll e v e l sw e r ed e t e r m i n e da sp r e v i o u s l yd e s c r i b e d[ 16].
Brieﬂy, weighed liver samples were saponiﬁed, extracted
with petroleum ether and subjected to reverse-phase high-
performance liquid chromatography on a Spheri-5, RP-
18, 5 reverse-phase column (Altech Associates). Values are
e x p r e s s e da sm g / go fl i v e r .
2.3. RNA Isolation. A portion of about 200mg was quickly
excised from livers of the rats and immediately homogenized
in 4mL of Tri-Reagent from Molecular Research Center
(Cincinnati, Ohio, USA) using a Polytron homogenizer at
room temperature. The remainder of the isolation steps was
carried out using volumes corresponding to 4x the manu-
facturer’s recommendations. RNA concentrations were de-
termined by diluting each sample 1:100 and measuring its
absorbance at 260nm.
2.4. Microarray Analysis . Isolated RNA was further puriﬁed
using the RNeasy kit from Qiagen. To demonstrate that the
RNA was indeed free of RNase activity, samples were incu-
b a t e di nw a t e ra t4 2 ◦Cf o r1h ra n dt h e ne x a m i n e do n1 %
agarose gels. An identical pattern of bands in unheated and
heated samples was obtained showing a lack of RNase activ-
ity. Microarray analysis was performed by the Moﬃtt Core
Facility (Tampa, FL) using the Aﬀymetrix GeneChip Instru-
ment system and the protocol established by Aﬀymetrix,
Inc. Ten μg of RNA each from the livers of 3 control and 3
cholesterol-fed rats was used in the analysis. The RNA was
converted to double-stranded cDNA using an oligo(dT)24
primer containing a T7 RNA polymerase recognition se-
quence. The product was transcribed into biotin-labeled
cRNAusingT7RNApolymerase.ThebiotinylatedcRNAwas
hybridized to Aﬀymetrix GeneChip Rat Genome 230 Plus
2.0 arrays, which detects about 28,000 genes. Multiple oligos
wereusedforeachgenewiththedataaveraged.Scannedchip
images were analyzed using GeneChip algorithms.
2.5. Real Time RT-PCR Analysis. To validate the microarray
results, we assessed the expression of a subset of genes via
real-time PCR essentially as described previously [14]. Total
RNA was resuspended in diethyl pyrocarbonate-treated wa-
ter. Twenty micrograms of RNA was then DNAse-treated
using the TURBO DNA-Free Kit from Ambion. cDNA was
prepared from 1μg of DNAse-treated RNA using the Reverse
Transcription System from Promega. The ﬁnal product was
brought up to 100μL, and a total of 2μL of the reverse
transcription reaction was then used for real-time PCR anal-
ysis. The primer sequences used are given in Table 1.P C R
was carried out according to the protocol from ABI Power
SYBR Green Master Mix, using a Chromo-4 DNA Engine
(Bio-Rad) with minor modiﬁcations. The program used for
ampliﬁcationwas(i)95◦Cfor5minutes,(ii)95◦Cfor15sec-
onds,(iii)61◦Cfor1minute(collectdata),and(iv)gotostep
(ii) 40 times, (v) 55◦C+0 . 5 ◦C each 10 seconds, ×80 (melt
curve). The results were quantiﬁed by the ΔΔCt method
using Microsoft Excel statistical programs and SigmaPlot
8.0. As a housekeeping gene, 18S ribosomal RNA was used.
Values are expressed relative to this.
2.6. Western Blot Analysis. At time of sacriﬁce, a portion of
liver was excised for protein analysis. Lysosome-free liver
microsomes were prepared according to the procedure pre-
viously described [17]. Liver microsomes (50μgo fp r o t e i n
per lane) from rats and mice were subjected to SDS-PAGE
and western blotting. Membranes were incubated overnight
with 1:2,000 dilution of cholesterol 7α hydroxylase primary
antibody generated in rabbits and generously provided to us
byDr.MatsRudlingin5%PBSTnonfatdrymilk.A1:10,000
dilution of Sheep anti Rabbit IGG was as the secondary
antibody. The West Pico Chemiluminesence kit was used for
detection with exposure times ranging from 5 to 20 seconds.
The blots were then stripped and reprobed with an antibody
to β-actin. The resulted were expressed relative to the β-actin
signal.
2.7.Statistics. Forthemicroarraydata,a2-taileddistribution
t-test, equal variance was used. The RT-PCR data are pre-
sented as means ± standard errors. P values using a 2-tailed
distribution t-test are given.
3. Results
3.1. Microarray Analysis. I no r d e rt oc o m p r e h e n s i v e l yi d e n -
tify the genes that exhibit signiﬁcant alterations in rates of
transcription in response to dietary cholesterol, microarrayJournal of Lipids 3
Table 1: Oligonucleotide sequences used for RT-PCR analysis.
Gene Primers Sequence (5  →3 )
SQLE Sense AGTGAACAAACGAGGCGTCCTACT
Antisense AAAGCGACTGTCATTCCTCCACCA
CYP51 Sense TTAGGTGACAACCTGACACACGCT
Antisense TGCTTACTGTCTTGCTCCTGGTGT
ABCG8 Sense GATGCTGGCTATCATAGGGAGC
Antisense TCTCTGCCTGTGATAACGTCGA
ABCG5 Sense TGAGCTCTTCCACCACTTCGACAA
Antisense TGTCCACCGATGTCAAGTCCATGT
ACAT2 Sense TTGTGCCAGTGCACGTGTCTTCTA
Antisense GCTTCAGCTTGCTCATGGCTTCAA
CYP7A Sense TGAAAGCGGGAAAGCAAAGACCAC
Antisense TCTTGGACGGCAAAGAGTCTTCCA
7DHCR Sense TCAGCTTCCAGGTGCTGCTTTACT
Antisense ACAATCCCTGCTGGAGTTATGGCA
D14SR Sense AATGGTTTCCAGGCTCTGGTGCTA
Antisense ATAAAGCTGGTGAGAGTGGTCGCA
HMGCR Sense ATTGCACCGACAAGAAACCTGCTG
Antisense TTCTCTCACCACCTTGGCTGGAAT
HMGCS Sense TTGGTAGTTGCAGGAGACATCGCT
Antisense AGCATTTGGCCCAATTAGCAGAGC
IGFBP1 Sense AGAGGAACAGCTGCTGGATAGCTT
Antisense AGGGCTCCTTCCATTTCTTGAGGT
LANS Sense ACTCTACGATGCTGTGGCTGTGTT
Antisense AAATACCCGCCACGCTTAGTCTCA
LIPIN2 Sense TCTGCCATGGACTTGCCTGATGTA
Antisense ACTCGTGGTACGTGATGATGTGCT
PPARα Sense AGACCTTGTGCATGGCTGAGAAGA
Antisense AATCGGACCTCTGCCTCCTTGTTT
PPARγ Sense CAATGCCATCAGGTTTGGGCGAAT
Antisense ATACAAATGCTTTGCCAGGGCTCG
SC4MEOX Sense ACCTGGCACTATTTCCTGCACAGA
Antisense AGCCTGGAACTCGTGATGGACTTC
Table 2: Serum and liver cholesterol levels.
Condition Serum Liver
Mg/100mL Mg/g
Normal 128 ± 53 . 2 ± 0.3
Cholesterol fed 102 ± 46 . 2 ± 0.5∗
∗P<0.01 compared with normal chow fed rats. A 2-tailed distribution t-
test, equal variance was used.
analysis was performed on hepatic RNA from Sprague-
Dawley rats fed either normal rodent chow or chow supple-
mented with 1% cholesterol for 5 days. This dietary regimen
does not raise serum cholesterol levels in these male Sprague
Dawley rats [2, 18]. Liver cholesterol levels are increased
about 2-fold (Table 2). This is similar to our previous ﬁnd-
ings with 2% cholesterol [16]. Thus, this treatment appears
to constitute a useful model for studying adaptive responses.
Surprisingly, the rates of transcription of relatively few
genes were altered more than 2-fold (Table 3). The largest in-
crease was observed for insulin-like growth factor-binding
protein 1. This increase of over 4-fold was conﬁrmed by
RT-PCR analysis (Table 5). A prominent increase of nearly
3-fold in hepatic cholesterol 7α hydroxylase expression was
observed. This would provide for increased production of
bile acids and more eﬃcient elimination of biliary choles-
terol, since this enzyme catalyzes the rate-limiting step of bile
acid synthesis. ABCG5 and ABCG8 expression was actual-
ly decreased (Table 4). These ATP-binding cassette (ABC)
transport proteins promote biliary secretion of neutral ster-
ols[19].Also,acetylCoAacetyltransferase2(ACAT2),which
esteriﬁes excess cholesterol, was signiﬁcantly decreased.
Strikingly, there was no change in hepatic LDL receptor ex-
pression.
Many of the genes exhibiting downregulated expression
in response to dietary cholesterol (Table 3) catalyze reactions
of the cholesterol biosynthetic pathway. Levels of mRNA for
the enzyme that catalyzes the rate-limiting reaction, HMG-
CoA reductase, were only decreased 2-fold. RT-PCR analysis
(Table 4) showed only a 1.4-fold decrease HMG-CoA re-
ductase, in agreement with previous results from Northern
blotting analysis [20]. The largest decrease (7.9-fold) was
observed for squalene epoxidase. This enzyme regulates lan-
osterol synthesis [21]. The next largest decrease among cho-
lesterol biosynthetic enzymes was seen for lanosterol 14α de-
methylase. The expression of several cholesterol biosynthetic
enzymes including Δ14 sterol reductase, sterol C4 methyl
oxidase-like, 7-dehydrocholesterol reductase, HMG-CoA
synthase 1, farnesyl diphosphate synthase, lanosterol syn-
thase, acetoacetyl CoA synthase, and mevalonate kinase were
decreased 2 to 4-fold (Table 4). Other cholesterol biosyn-
thetic enzymes such as sterol-C5-desaturase, phosphomeval-
onate kinase, diphosphomevalonate decarboxylase, 24-dehy-
drocholesterol reductase and dehydrogenase/reductase (SDR
family) member 7 were decreased 1.5- to 1.9-fold. Other
genes of interest whose expression was decreased by dietary
cholesterol were SREBP-2 (1.4-fold, P = 0.028) and PCSK9
(1.5-fold, P = 0.022).
3.2. RT-PCR Analysis. Quantitative RT-PCR was utilized to
examine a subset of the altered genes that were identiﬁed
via microarray analysis. The results are presented in Table 5
and correlate with those seen in the microarray analysis. For
example, the expression of squalene epoxidase (Sqle) and
lanosterol 14α demethylase (Cyp51A1) were decreased by
8.29 and 4.53-fold, respectively (Table 5) as compared with
7.9 and 3.5-fold in the microarray analysis (Table 4). The
relative fold changes in ABCG5 and 8, HMG-CoA synthase,
ACAT-2, lanosterol synthase, sterol C4 methyl oxidase-like,
lipin 2, cholesterol 7α hydroxylase, and 7-dehydrocholesterol
reductase also agree very closely, providing further veriﬁca-
tion of the data obtained from the microarray analysis.
3.3. Western Blotting Analysis. Since the increase in rat liver
cholesterol 7α hydroxylase mRNA caused by dietary choles-
terol could be important for the elimination of cholesterol4 Journal of Lipids
Table 3: Microarray analysis identifying genes upregulated by dietary cholesterol.
Normal Cholesterol Fold diﬀ Gene
386 507 439 2377 1264 2347 +4.5∗∗ Insulin-like growth factor binding protein 1
476 457 536 2322 2418 988 +3.9∗ B-cell leukemia/lymphoma 6 (predicted)
3597 5311 8493 16287 17914 12394 +2.7∗∗ Cholesterol 7α hydroxylase
73 304 546 853 747 746 +2.5∗ Similar to Ran-binding protein 2 (predicted)
2287 1733 1841 5590 5726 5166 +2.8∗∗ Zinc ﬁnger protein 354A
127 387 320 756 494 773 +2.4∗ PPARα
253 372 250 766 759 536 +2.4∗∗ Lipin 2 (predicted)
34 131 263 332 303 344 +2.3∗ Zinc ﬁnger, matrin-like (predicted)
207 684 856 1358 1006 1277 +2.1∗ HGPRTase
4255 2830 4209 9654 4959 8308 +2.0 Glucose-6-phosphatase
∗P<0.05; ∗∗P<0.01. A 2-tailed distribution t-test, equal variance was used.
Table 4: Microarray analysis identifying genes downregulated by dietary cholesterol.
Normal Cholesterol Fold diﬀ Gene
1185 2381 1598 219 232 203 −7.9∗∗ Squalene epoxidase
588 783 426 148 84 143 −4.8∗∗ ABCG8
574 373 195 51 144 62 −4.5 Hypo protein XP 580018
2353 3066 2285 735 783 503 −3.8∗ Acetyl CoA Acetyltransferase2
10377 11676 10752 2690 3350 3329 −3.5∗∗ Lanosterol 14α demethylase
3890 4874 3668 929 1280 1426 −3.4∗∗ Delta 14 sterol reductase
1049 893 1196 186 216 542 −3.3∗∗ Cytokine inducible SH2 protein
238 316 242 65 115 76 −3.1∗∗ Nuc factor, erythroid derived 2
733 1023 760 233 232 345 −3.1∗∗ Ephrin A5
1998 608 524 340 343 375 −3.0 Dual speciﬁcity phosphatase1
11250 14322 9729 3511 4636 4315 −2.8∗∗ Sterol C4 methyl oxidase-like
6083 6326 4997 1961 2597 2103 −2.6∗∗ 7-Dehydrocholesterol reductase
2851 2771 2112 1027 879 1055 −2.6∗∗ Solute carrier family 25 mem 30
14079 17666 16412 5555 6296 7154 −2.5∗∗ HMG-CoA Synthase 1
14890 13208 12147 5146 5920 5178 −2.5∗∗ Farnesyl diphosphate synthase
1857 2636 1792 882 1025 635 −2.5∗∗ Lanosterol synthase
4946 5502 4267 1503 2456 1667 −2.6∗∗ Farnesyl diphos transferase 1
1695 2518 1567 870 834 814 −2.3∗ ABCG5
13476 13702 14018 6048 7357 5541 −2.2∗∗ Fatty acid desaturase 1
10599 8161 6620 3050 4215 4797 −2.1∗ Hemato expressed homeobox
444 591 470 225 288 205 −2.1∗∗ Acetoacetyl CoA synthase
1269 1465 1136 604 749 548 −2.0∗∗ Hypo protein XP 579849
10087 11135 8727 4223 5304 5287 −2.0∗∗ HMGCR
2516 2177 2744 1138 1049 1509 −2.0∗∗ Forkhead box A2
848 1080 873 538 444 432 −2.0∗∗ Mevalonate kinase
∗P<0.05; ∗∗P<0.01. A 2-tailed distribution t-test, equal variance was used.
from the body, we wished to determine whether levels of
this protein are actually increased. For comparison purposes,
we examined the eﬀect of dietary cholesterol on mouse
liver cholesterol 7α hydroxylase protein. Cholesterol 7α
hydroxylase protein levels were much higher in rat liver than
in mouse liver (Figure 1). Supplementing the chow with
1% cholesterol increased hepatic cholesterol 7α hydroxylase
p r o t e i nl e v e l si nr a t sf r o m1 . 2 2± 0.78 to 6.52 ± 2.27
(4 chow-fed rats compared with 5 cholesterol-fed animals
with a P = 0.011). In contrast, little eﬀect on the levels in
mouse liver was seen even when 2% cholesterol was added to
the diet (Figure 1).
3.4.Time-CourseExperiment. Atime-courseexperimentwas
conducted to determine how rapidly dietary cholesterol
reduces the expression of Sqle and Cyp51. RT-PCR analysis,Journal of Lipids 5
Table 5: RT-PCR analysis.
Gene Normal Cholesterol Fold P value
ABCG5 1.00 ± 0.07 0.67 ± 0.09 −1.49 0.018
ABCG8 1.02 ± 0.17 0.17 ± 0.03 −6.00 0.003
HMG-CoA synthase 1.03 ± 0.23 0.23 ± 0.01 −4.48 0.008
Squalene epoxidase 1.17 ± 0.26 0.14 ± 0.03 −8.29 0.002
Lanosterol 14α demeth 0.71 ± 0.28 0.16 ± 0.01 −4.53 0.027
Delta 14 sterol reductase 1.03 ± 0.31 0.19 ± 0.15 −5.33 0.013
Lanosterol synthase 1.12 ± 0.58 0.33 ± 0.14 −3.39 0.083
ACAT-2 1.00 ± 0.08 0.31 ± 0.07 −3.20 0.001
Sterol C4 Me Ox like 1.04 ± 0.31 0.39 ± 0.50 −2.65 0.128
7-Dehydrocholesterol red 1.01 ± 0.13 0.50 ± 0.06 −2.00 0.004
HMG-CoA reductase 1.02 ± 0.26 0.73 ± 0.28 −1.40 0.261
PPAR gamma 1.07 ± 0.40 1.02 ± 0.89 −1.04 0.944
PPAR alpha 1.01 ± 0.18 1.06 ± 0.44 +1.05 0.852
Lipin 2 (predicted) 1.03 ± 0.29 1.64 ± 0.42 +1.59 0.105
Chol 7α hydroxylase 1.17 ± 0.35 3.27 ± 0.97 +2.79 0.044
IGFBP1 1.02 ± 0.31 4.30 ± 1.90 +4.22 0.042
A 2-tailed distribution t-test, equal variance was used.
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Figure 1: Comparison of the eﬀects of dietary cholesterol on
hepatic cholesterol 7α hydroxylase protein levels in rats and Mice.
Rats (R) and mice (M) were fed normal (N) chow diets with or
without 1% or 2% cholesterol (C) for 5 days. A representative West-
ern blot of hepatic microsomal cholesterol 7α hydroxylase protein
is presented.
as shown in Figures 2 and 3, demonstrates that the decrease
in Sqle occurred more rapidly. Both Sqle and Cyp51 de-
creased progressively over a 3-day period. This agrees with
the time course for the reduction in translation of HMG-
CoA reductase mRNA [22].
4. Conclusion
Sprague Dawley rats from Harlan fed the grain-based Tek-
land 22/5 rodent chow diet resist a high cholesterol diet-
induced increase in serum cholesterol as reported previously
[2, 16]. They do show increases in liver cholesterol levels
(Table 2). This indicates that dietary cholesterol is eﬀectively
taken up by the intestine, where Niemann-Pick C1-like 1
protein facilitates its uptake [23]. The resulting chylomicron
remanents are taken up by the liver. With the increased
cholesterol from the diet, the activity of the hepatic LDL
receptor, as determined from its rate of turnover, is markedly
decreased [18]. Thus, the cycling of this receptor, located
in the cholesterol-rich caveolae portion of the plasma
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Figure 2: Eﬀect of cholesterol feeding on hepatic squalene epoxi-
dase mRNA levels. Rats were fed a diet containing 1% cholesterol
for the indicated number of days. Hepatic mRNA levels were
determinedbyRT-PCR.Valuesaregivenasmeans ±StandardError
f o r3t o6r a t sp e rt i m ep o i n t .∗P<0.05; ∗∗P<0.01.
membrane [24], virtually stops [18]. The levels of hepatic
L D Lr e c e p t o rp r o t e i na n dm R N Ad on o t ,h o w e v e r ,c h a n g e
[18]. Since the liver must play a key role in adapting to and
resisting the increase load of cholesterol, we conducted a
microarray study to investigate changes in hepatic mRNA
levels.
Of all the hepatic genes examined, the most dramatic
changes seen in response to dietary cholesterol were the de-
creases in Sqle and Cyp51. These changes seen in the mi-
croarray experiment were conﬁrmed by RT-PCR. When lan-
osterol levels are decreased as occurs when Sqle expression is
decreased, the diﬀerent Kms of the three reactions catalyzed6 Journal of Lipids
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Figure 3: Eﬀect of cholesterol feeding on hepatic lanosterol 14α
demethylase mRNA levels. Rats were fed a diet containing 1%
cholesterol for the indicated number of days. Hepatic mRNA levels
were determined by RT-PCR. Values are given as means ± Standard
Error for 3 to 6 rats per time point. ∗P<0.05; ∗∗P<0.01.
by Cyp51 come into play. The Km for the formation of 3β-
hydroxylanosterol-8-en-32-al is 56μM while the Km for its
destruction (conversion to 4 dimethylcholesta 8, 14 dien-
3β-ol) is 368μM[ 25]. Although there would be suﬃcient
lanosterol for the ﬁrst reaction catalyzed by CYP51 (for-
mation of 3β-hydroxylanosterol-8-en-32-al), because of the
low Km, its subsequent conversion to 4 dimethylcholesta
8, 14 dien-3β-ol would be slow due to the high Km for
this reaction. Thus, 3β-hydroxylanosterol-8-en-32-al would
accumulate. This oxylanosterol is known to act to decrease
the rate of translation of hepatic HMG-CoA reductase in
CHO cells [26]. The structural analogue, 15α-ﬂuoro-3β-
hydroxylanost-7-en-32-aldehyde has also been reported to
inhibit translation of HMG-CoA reductase mRNA in CHO
cells [27]. In addition, it has been demonstrated that feeding
the nonmetabolizable oxylanosterol analogue, 15 oxa-32-
vinyllanost-8-ene-3β, 32 diol to rats results in a marked de-
crease in translation of hepatic HMG-CoA reductase mRNA
which mimics the eﬀect of dietary cholesterol [28]. Thus,
dietary cholesterol-mediated decreases in Sqle and Cyp51
transcription lead to decreased translation of hepatic HMG-
CoA reductase mRNA.
In this microarray study, a 2-fold decrease in HMG-CoA
reductase expression was observed in response to dietary
cholesterol. The SREs in the promoters of both Sqle and
Cyp51 [29, 30] have been shown to be responsive to SREBP2
and would be expected to be downregulated by cholesterol
feeding.However,theSREsequenceintheHMG-CoAreduc-
tase promoter does not agree well with the consensus SRE,
which may explain the only modest decrease in HMG-CoA
reductase transcription in response to dietary cholesterol.
Previous Northern blotting analysis and nuclear run-on
studies showed only slight decreases in mRNA levels and
rates of transcription for hepatic HMG-CoA reductase [20,
31]. However, enzyme activity and protein levels drop to
a couple percent of control values [20, 31]. This is due
primarily to a marked decrease in the rate of translation of
HMG-CoA reductase mRNA caused by feeding cholesterol
[22]. The decrease in the rate of translation of HMG-CoA
reductase mRNA is due to shift from association of the
mRNA with polysomes to monosomes caused by dietary
cholesterol [32]. The present observations are predicted by
the proposed two-step model for feedback regulation of
hepatic HMG-CoA reductase gene expression [33]. In this
model, increased hepatic cholesterol leads to decreased
formation of mature SREBP2 and decreased transcription of
Sqle and Cyp51. This in turn results in accumulation of 3β-
hydroxylanosterol-8-en-32-al, which acts to decrease trans-
lation of hepatic HMG-CoA reductase mRNA [20].
In addition to adapting to excess dietary cholesterol
by decreasing the rate of hepatic cholesterol biosynthesis,
adaptations in bile acid pathways also occurred. A 2.7-fold
increase was observed in cholesterol 7α hydroxylase expres-
sion, whichistheenzymethatcatalyzestherate-limiting step
in bile acid synthesis (Table 3). We have previously observed
by Northern blotting analysis that hepatic cholesterol 7α
hydroxylase mRNA is markedly increased in rats [16]. Para-
doxically, the microarray analysis did not show increases in
expression of the ABCG5/G8 transporters. Instead, decreases
in the expression of both ABCG5 and ABCG8 wereobserved.
The expression of ABCG8, in particular, was markedly
decreased. These ﬁndings were conﬁrmed by RT-PCR anal-
ysis (Table 4). This is in contrast to the study in mice where
ABCG5 expression was reported to be upregulated about 2-
fold in response to dietary cholesterol [10]. In agreement
with previous Northern blotting analysis, cholesterol feeding
did not aﬀect hepatic LDL receptor mRNA levels [18].
However,therateofcyclingandhenceactivityofthereceptor
is markedly decreased in response to dietary cholesterol [18].
Western blotting analysis showed that dietary cholesterol
increases hepatic cholesterol 7α hydroxylase protein levels in
rats but not in mice (Figure 1). Also, mice exhibited lower
levels of cholesterol 7α hydroxylase protein in their livers.
This is in agreement with a previous study [34] showing
that dietary cholesterol caused a 3-fold increase in hepatic
cholesterol 7α hydroxylase mRNA in rats with much less
eﬀect in C57BL/6J mice. Other reports showed that dietary
cholesterol may act to increase or decrease cholesterol 7α
hydroxylase mRNA levels in C57BL/6J mice depending on
the type of fat added to the diet [35, 36]. Diets supple-
mented with olive oil (monounsaturated fatty acids) caused
increased expression of hepatic cholesterol 7α hydroxylase.
Western blotting analysis of cholesterol 7α hydroxylase was
not preformed in these previous studies.
In a recent study comparing the responses of hamsters
and rats to cholesterol-enriched diets, it was found that
hepatic cholesterol 7α hydroxylase expression in hamsters
was not increased in response to cholesterol feeding [37].
This is in contrast with the increase seen in rats. However,
hamsters do not adapt well to cholesterol supplemented
diets, as their serum cholesterol levels are increased about 2-
fold in response to a 0.1% cholesterol diet [37]. Also, ham-
sters express much lower (only 2 percent of that of rats) basal
levels of hepatic HMG-CoA reductase [2], which renders
them less able to resist the eﬀects of dietary cholesterol [13].Journal of Lipids 7
The eﬀect of a high cholesterol diet on the expression of
genes in livers of mice has been previously investigated by
microarray analysis [10]. In that study, Sqle was found to be
downregulated3.4and2.8-foldinmalesandfemales,respec-
tively. This correlates with the decrease (7.9-fold) observed
for hepatic Sqle expression in the present study. Apparently,
no changes in CYP51 or cholesterol 7α hydroxylase expres-
sion were observed in the previous study [10]. HMG-CoA
reductase was decreased 2-fold in males with no eﬀect seen
in females [10]. The greatest change in the previous study
was observed for a disintegrin and metalloprotease domain
11 family member (Adam 11) which was upregulated 5 to
11-fold in the microarray and TaqMan analysis. ADAM 11 is
a speciﬁc aggrecanase induced by interleukin 6 [38]w h i c h
would promote an inﬂammatory response. In the present
analysis, no change in Adam 11 expression was observed.
A signiﬁcant increase in serum amyloid A3, an acute phase
reactant, was also observed in the earlier study [10]. An
increase in this protein also indicates an inﬂammatory re-
sponse to a high cholesterol diet.
The largest cholesterol-induced increase in hepatic gene
expression in the present study was observed for insulin-
like growth factor-binding protein 1 (IGFBP1), which was
measured at over 4-fold by both microarray and RT-PCR
analysis. This protein is produced by the liver during
inﬂammation [39], possibly caused by dietary cholesterol.
Increasedlevelsareassociatedwithanelevatedriskofcardio-
vascular disease in type 2 diabetic patients [40]. IGFBP1 may
alsobeamarkerforinsulinresistance[41]andbeinvolvedin
the development of type 2 diabetes [42]. It may be protective
against the growth of certain cancers by binding insulin-like
growth factor-1, a potent mitogen [43].
In summary, a comprehensive examination of the adap-
tive hepatic transcriptional responses to dietary cholesterol
was conducted using microarray and RT-PCR analysis. The
data suggest that rats adapt, in part, to excess dietary choles-
terol by markedly reducing hepatic cholesterol biosynthesis
and enhancing elimination of cholesterol as bile acids due
to induction of cholesterol 7α hydroxylase. A large increase
in insulin-like growth factor-binding protein 1 was also
observed. This could partially explain the inﬂammatory re-
sponse associated with excess dietary cholesterol.
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